RE:RE:$ACOG - not much movement tdwell that blurb gave it a nice little boost today, not a lot shares out so it won't take much good news to get things really rolling here, it sounds like this alzheimer drug could go thru trials at a much faster pace due to it's make up (and less side effects than others) than other drugs so things look to me like approval could come quicker than some might think, all jmho.
cheers ferret